DAS28 and rheumatoid arthritis: The need for standardization

Musculoskeletal Care

Volumn 9, Issue 4, 2011, Pages 222-227

  Porter, Duncan ^a   Gadsby, Kate ^b   Thompson, Paul ^c   White, Jo ^d   McClinton, Catherine ^e   Oliver, Sue ^f  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b ROYAL DERBY HOSPITAL   (United Kingdom)

^c POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^e CHARING CROSS HOSPITAL   (United Kingdom)

^f Minerva Health Centre   (United Kingdom)

Author keywords

Assessment; DAS; DAS28; Joint score; Rheumatoid arthritis; Standardization

Indexed keywords

C REACTIVE PROTEIN;

ARTHROGRAPHY; ARTICLE; BLOOD; DISEASE COURSE; DRUG MONITORING; EDEMA; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMAN; JOINT; MALE; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; REPRODUCIBILITY; RHEUMATOID ARTHRITIS; SICKNESS IMPACT PROFILE; STANDARD;

ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; C-REACTIVE PROTEIN; DISEASE PROGRESSION; DRUG MONITORING; EDEMA; FEMALE; HEALTH STATUS; HUMANS; JOINTS; MALE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 82155162456     PISSN: 14782189     EISSN: 15570681     Source Type: Journal    
DOI: 10.1002/msc.218     Document Type: Article

References (19)

1. Fransen J, Stucki G, van Riel P (2003). Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI). Arthritis Care and Research 49: S214-24.
2. Fransen J, van Riel P (2009). The Disease Activity Score and the EULAR response criteria. Rheumatic Disease Clinics of North America 35: 745-57, vii-viii.
3. Gardiner P, Bell A, Taggart A, Wright G, Kee F, Smyth A, McKane R, Lee J, Rooney M, Whitehead E (2005). A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 64: 506-7.
4. Hensor E, Emery P, Bingham S, Conaghan P, The YEAR Consortium (2010). Discrepancies in categorizing rheumatoid arthritis patients by DAS-28(ESR) and DAS-28(CRP): Can they be reduced? Rheumatology 49: 1521-9.
5. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N (2007). Comparison of Disease Activity Score (DAS)28 - erythrocyte sedimentation rate and DAS28 - C-reactive protein threshold values. Annals of the Rheumatic Diseases 66: 407-9.
6. Lindsay K, Ibrahim G, Sokoll K, Tripathi M, Melsom R, Helliwell P (2009). The composite DAS score is impractical to use in daily practice: Evidence that physicians use the objective component of the DAS in decision making. Journal of Clinical Rheumatology 15: 223-5.
7. Luqmani R, Hennell S, Estrach C, Basher D, Birrell F, Bosworth A, Burke F, Callaghan C, Candal-Couto J, Fokke C, Goodson N, Homer D, Jackman J, Jeffreson P, Oliver S, Reed M, Sanz L, Stableford Z, Taylor P, Todd N, Warburton L, Washbrook C, Wilkinson M (2009). British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Rheumatoid Arthritis (the first two years). Rheumatology 48(4): 436-9.
8. Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, Yasuda M, Saisho K, Shimada K, Tohma S (2007). Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Annals of the Rheumatic Diseases 66: 1221-6.
9. Marhadour T, Jousse-Joulin S, Chales G, Grange L, Hacquard C, Loeuille D, Sellem J, Albert J, Bentin J, Valckenaere I, d'Agostino M, Etchepare F, Gaudin P, Hudry C, Dougados M, Saraux A (2010). Reproducibility of joint swelling assessments in long-lasting rheumatoid arthritis: Influence on disease activity score-28 values (SEA-Repro Study Part I). Journal of Rheumatology 37: 932-7.
10. National Institute for Health and Clinical Excellence (2009). NICE recommends treatments for rheumatoid arthritis. Available at [Accessed 19 January 2011].
11. Prevoo M, van't Hof M, Kuper H, van Leeuwen M, van de Putte L, van Riel P (1995). Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and Rheumatism 38: 44-8.
12. Scott D, Choy E, Greeves A, Isenberg D, Kassinor D, Rankin E, Smith E (1996). Standardising joint assessment in rheumatoid arthritis. Clinical Rheumatology 15: 579-82.
13. Shaver T, Anderson J, Weidensaul D, Shahouri S, Busch R, Mikuls T, Michaud K, Wolfe F (2008). The problem of rheumatoid arthritis disease activity and remission in clinical practice. Journal of Rheumatology 35: 1015-22.
14. Smith N, Gadsby K, Butt S, Carruthers D, Deeming A, Ledingham J, Fletcher M, Mulherin D, Roskell S, Kay L, Nicholl K, Cooper R, Worsley A, Deighton C (2007). Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centres. Rheumatology 46: 1557-9.
15. Smith N, Ding T, Butt S, Gadsby K, Deighton C (2008). The importance of the baseline Disease Activity Score 28 in determining responders and non-responders to anti-TNF in UK clinical practice. Rheumatology 47: 1389-91.
16. Smolen J, Landewé R, Breedveld F, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma J, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien T, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott D, Sokka T, Valesini G, van Vollenhoven R, Winthrop K, Wong J, Zink A, van der Heijde D (2010). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Annals of the Rheumatic Diseases 69: 964-75.
17. Soubrier M, Dougados M (2005). How to assess early rheumatoid arthritis in daily clinical practice. Best Practice & Research. Clinical Rheumatology 19: 73-89.
18. van de Heijde D, van't Hof M, van Riel P, Theunisse L, Lubberts E, van Leeuwen M, van Rijswijk M, van de Putte L (1990). Judging disease activity in clinical practice in rheumatoid arthritis: First step in the development of a disease activity score. Annals of the Rheumatic Diseases 49: 916-20.
19. Wells G, Becker J-C, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, van Riel P (2009). Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Annals of the Rheumatic Diseases 68: 954-60.